This article appears in the following Europace issue: Spotlight Issue: Cardiac Imaging in EP and CRT [View the issue table of contents]
IMAGING IN CATHETER ABLATION FOR AF
Imaging in catheter ablation for atrial fibrillation: enhancing the clinician's view
Service de Rythmologie, Hôpital Cardiologique du Haut-Lévêque, Université Victor Segalen Bordeaux II, Avenue de Magellan, Bordeaux-Pessac 33604, France
* Corresponding author. Tel: +33 5 57 65 64 71; fax: +33 5 57 65 65 09.E-mail address: sebastien.knecht{at}chu-brugmann.be
| Abstract |
|---|
|
|
|---|
Catheter ablation is an effective treatment for symptomatic atrial fibrillation. A thorough understanding of the left atrium anatomy and its adjacent structures is critical for the success of the procedure and for avoiding complications. Pre-procedural imaging aims at determining left atrial size, anatomy, and function and is also used to rule out an atrial thrombus. During the procedure, while fluoroscopy remains the gold standard imaging modality for guiding transseptal catheterization and catheter ablation, numerous other imaging modalities have been developed to improve 3D navigation and ablation. Finally, post-operative imaging intends to monitor heart function and to search for potential complications like pulmonary vein stenosis or the rare but dramatic atrio-oesophageal fistula. This review discusses the relative merits of all imaging modalities available in the context of catheter ablation of atrial fibrillation.
Key Words: Imaging, Atrial fibrillation, Fluoroscopy, Computed tomography scan, Magnetic resonance imaging, Echocardiography, Contrast, Ablation, Electrophysiology
| Introduction |
|---|
|
|
|---|
Catheter ablation is an effective treatment for symptomatic paroxysmal and persistent atrial fibrillation (AF).1
| Pre-procedural imaging |
|---|
|
|
|---|
Left atrial size, anatomy, and function
A transthoracic echocardiogram (TTE) has obviously to be performed in all patients with AF prior to the consideration of ablation. A TTE is mandatory to rule out any other cardiac pathology that may have led to AF, such as mitral valve disease, left ventricular dysfunction, and hypertensive heart disease. In addition, LA dimensions can be accurately assessed, giving an estimate of the duration of AF and being independently predictive of the procedural termination of AF with catheter ablation.7
Determination of gross cardiac anatomy and landmarks
Pulmonary vein (PV) isolation is the cornerstone of all ablation strategies for both paroxysmal and persistent AF, and therefore an accurate knowledge of an individuals PV anatomy is useful prior to the procedure. The majority of patients have four PVs, two superior and two inferior with independent ostia draining separately into the LA. A number of variations have been described in the literature, the commonest of which are: left common ostium (up to 83% of patients), right common ostium (up to 40%), and a separate origin for the right middle PV (up to 27% of patients).8
Although prior knowledge of the diameter of the PVs is useful in the sizing of circular mapping catheters, it is essential if balloon-based ablation catheters are to be used, as a close approximation of the balloon to the PV ostia is required for successful isolation.9
Although transoesophageal echocardiography (TOE) can provide an assessment of PV diameter, the most accurate measure is provided by computed tomography (CT) scanning or magnetic resonance imaging (MRI).10
Using these scanning modalities, the oval nature of the left-sided PVs is more readily appreciated, with a superior–inferior diameter larger than the anterior–posterior dimension, in comparison with the more circular nature of the right-sided PVs. Additionally, CT or MRI can provide useful information about other atrial or venous structures targeted during the ablation. It has been shown that the septal anatomy is accurately visualized on CT,11
which may be helpful during the procedure, however, TOE is the most accurate modality to detect the presence of a patent foramen ovale.12
Detection of atrial thrombus
Screening for the presence of an atrial thrombus is mandatory prior to AF ablation for patients at risk, as catheter manipulation could dislodge a thrombus with the potential for embolic complications. Current guidelines suggest that the management of patients with AF at the time of the procedure should be the same as that for a cardioversion.13
They should have TOE performed within 48 h of the procedure regardless of whether they have been anticoagulated with warfarin or not prior to cardioversion. Although a CT scan (especially 64-slice) can rule out a thrombus with a high negative predictive value,14
the differentiation between pectinate muscle, blood stasis (smoke), and thrombus within the LA appendage is challenging. For low-risk lone paroxysmal AF with prior anticoagulation, there is some uncertainty about the utility of performing routine thrombus detection.13
In this case, TTE can be used to risk-stratify patients before performing TOE with a very high negative predictive value.15
| Procedural imaging |
|---|
|
|
|---|
Trans-septal catheterization
The majority of the population does not have a patent foramen ovale and, thus, requires a trans-septal puncture for access into the LA. Using the standard Brockenbrough approach (with fluoroscopy only), a jump is seen when pulling the trans-septal sheath down the septum, indicating the position of the foramen ovale.16
Catheter ablation
Pulmonary vein isolation
Isolation of the PVs has shifted to proximal ablations, either ostial or antral, from earlier more distal ablations that led to an unacceptable rate of PV stenosis. Therefore, delineation of the veno-atrial junction is essential. Using catheter manipulation alone, the inferior portion of the PV can be readily determined by advancing the ablation catheter inside the PV with a downward deflection of the tip, and then dragging back during fluoroscopic monitoring to register the drop off to the LA. Pulmonary vein angiography in orthogonal views gives supplementary information and is easily performed. A CT or MRI scan, merged with a three-dimensional reconstruction map or overlaid on live fluoroscopic images,19
offers even more detailed anatomy. Intra-cardiac echocardiography provides additional Doppler colour flow imaging that can be used for monitoring of real-time PV ostial narrowing, estimation of the tissue contact, and detection of thrombus, coagulum, or micro-bubbles.20
–24
Atrial ablation
In persistent AF, it has emerged that the atrial substrate maintaining AF needs to be modified. Electrogram-based ablation and linear ablation can be facilitated by ICE, CT, and MRI techniques, which can be integrated with three-dimensional mapping systems25
–27
(Figures 1 and 2) or overlaid on real-time fluoroscopic images.19
,28
Merging of three-dimensional images using CT, MRI, or ICE with three-dimensional mapping systems offers precise details of anatomy with real-time positioning of catheters during AF ablation (Figures 1 and 2). This has been shown to improve the success of ablation, decrease the occurrence of PV stenosis, and reduce fluoroscopic time.29
Rotational angiography has also shown promising results and can be performed at the time of the ablation procedure.30
,31
|
|
We have evaluated the feasibility of an advanced overlay system between CT anatomical information and two-dimensional fluoroscopy. This system allows viewing the inside of the CT volume (endoscopic view), correcting the three-dimensional CT image dimensions in relation to the X-ray cone beam of the C-arm system, and tagging catheter positions on the CT volume (Figure 3). In addition to fluoroscopic time reduction,19
|
Oesophagus
The rate of oesophageal injury (oesophagitis, necrosis, or ulcer) as visualized by endoscopy has been reported in up to 35% of patients.32
Lesion assessment
Lesion assessment can be indirectly evaluated at the time of ablation by looking at the electrogram amplitude, impedance, and temperature at the tip of the ablation catheter. Intra-cardiac echocardiography offers a direct vision of the contact between the catheter tip and the atrial surface.21
Other tools with robotic systems indirectly assess contact by measuring force applied on the surface of the heart.37
One study evaluated the use of high spatial resolution MRI following ablation to assess for gaps.38
With delayed enhancement, it was possible to visualize scars created by ablation and to see areas around PVs where the tissue was not altered.38
Present imaging modalities can identify areas of anatomical scar but the resolution is not adequate enough to identify islands of electrically intact tissue within the scar areas. Therefore, the only method to assess the electrical completeness of linear lesions is by using mapping catheters and relevant pacing manoeuvres.
| Post-operative imaging |
|---|
|
|
|---|
Remodelling after AF ablation
Restoration of sinus rhythm by catheter ablation has been shown to improve LA and left ventricular function. Acutely, restoration of sinus rhythm can be followed by transient atrial dysfunction or stunning with transient decrease in the LA appendage emptying velocity and emptying fraction by TOE.39
Assessment of complications
Early complications
Pericardial effusion can occur during catheter ablation, but may manifest several hours following the procedure and for this reason, patients should have a repeat TTE prior to discharge following the procedure, especially if there is haemodynamic compromise. Transthoracic echocardiogram is the study of choice as it is easily and rapidly performed and invaluable in the follow-up of the effusion.
Pulmonary vein stenosis
Pulmonary vein stenosis decreases in frequency following AF catheter ablation because of more proximal PV isolation.42
There is discordant data in the literature concerning the incidence of iatrogenic PV stenosis after AF ablation, varying from 0 to 42%.43
–45
This can be explained by the lack of a standard definition of PV stenosis, the different imaging modalities used to diagnose PV stenosis, and the inhomogeneity in follow-up. Pulmonary vein stenosis tends to occur immediately after the ablation.44
,45
In most patients, there will be a progressive narrowing of the stenosis, although acute PV stenosis can rarely heal spontaneously. Of note, some patients without acute/peri-procedural narrowing will still have significant PV stenosis revealed by later imaging. Computed tomography and MR angiography are considered the gold standards for the detection of PV stenosis. Although pulmonary angiography is accurate, due to its invasive nature and the need for multiple scans over time, this is not the preferred option. Functional testing with single photon emission computed tomography and magnetic resonance perfusion scanning have also been studied42
,44
and were able to detect decreased perfusion in patients with PV stenosis which later improved following restoration of flow.42
,44
Oesophageal injury
The dramatic atrio-oesophageal fistula is reported in 0.1–1% of cases but is fatal in 80%.46
If such a diagnosis is suspected, TOE and oesophagoscopy are to be avoided. These increase the risk of further oesophageal injury and air emboli. The examination of choice is CT with water soluble contrast, which allows the fistula to be visualized. Magnetic resonance imaging can also be used in this situation.
| Conclusion |
|---|
|
|
|---|
While TTE and fluoroscopy are mandatory for all patients in the context of AF ablation, other imaging modalities are dependant on the practice and experience of each centre. There must be a balance between reduction in irradiation and procedural duration, improvement in catheter manipulation, financial considerations, and the side effects of each imaging procedure as it may result in increased contrast use, increased irradiation, and a false impression of safety. One must keep in mind that the number one imaging modality during AF catheter ablation remains the display of electrograms.
Conflict of interest: P.J., M.H. and M.H. have served on the advisory board of, and received lecture fees from Biosense-Webster. S.K. has received lecture fees from Biosense-Webster. P.J. and S.K. have received lecture fees from Philips Medical Systems. S.K. has received lecture fees from St Jude Medical.
| Funding |
|---|
|
|
|---|
S.K. is supported by the Belgian Foundation for Cardiac Surgery. M.D.O. is supported by the British Heart Foundation.
| References |
|---|
|
|
|---|
[1] Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 339:659–66.
[2] Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med (2006) 354:934–41.
[3] Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation (2004) 109:327–34.
[4] Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, et al. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation (2004) 110:2090–6. (Epub October 2004).
[5] Haissaguerre M, Sanders P, Hocini M, Takahashi Y, Rotter M, Sacher F, et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol (2005) 16:1125–37.[CrossRef][Web of Science][Medline]
[6] Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol (2004) 43:2044–53.
[7] ONeill MD, Jais P, Hocini M, Sacher F, Klein GJ, Clementy J, et al. Catheter ablation for atrial fibrillation. Circulation (2007) 116:1515–23.
[8] Wood MA, Wittkamp M, Henry D, Martin R, Nixon JV, Shepard RK, et al. A comparison of pulmonary vein ostial anatomy by computerized tomography, echocardiography, and venography in patients with atrial fibrillation having radiofrequency catheter ablation. Am J Cardiol (2004) 93:49–53.[Web of Science][Medline]
[9] Sarabanda AV, Bunch TJ, Johnson SB, Mahapatra S, Milton MA, Leite LR, et al. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol (2005) 46:1902–12.
[10] Mansour M, Holmvang G, Sosnovik D, Migrino R, Abbara S, Ruskin J, et al. Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J Cardiovasc Electrophysiol (2004) 15:387–93.[CrossRef][Web of Science][Medline]
[11] Graham LN, Melton IC, MacDonald S, Crozier IG. Value of CT localization of the fossa ovalis prior to transseptal left heart catheterization for left atrial ablation. Europace (2007) 9:417–23.
[12] Fisher DC, Fisher EA, Budd JH, Rosen SE, Goldman ME. The incidence of patent foramen ovale in 1,000 consecutive patients: a contrast transesophageal echocardiography study. Chest (1995) 107:1504–9.[CrossRef][Web of Science][Medline]
[13] Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace (2007) 9:335–79.
[14] Kim YY, Klein AL, Halliburton SS, Popovic ZB, Kuzmiak SA, Sola S, et al. Left atrial appendage filling defects identified by multidetector computed tomography in patients undergoing radiofrequency pulmonary vein antral isolation: a comparison with transesophageal echocardiography. Am Heart J (2007) 154:1199–205.[CrossRef][Web of Science][Medline]
[15] Ellis K, Ziada KM, Vivekananthan D, Latif AA, Shaaraoui M, Martin D, et al. Transthoracic echocardiographic predictors of left atrial appendage thrombus. Am J Cardiol (2006) 97:421–5.[CrossRef][Web of Science][Medline]
[16] Brockenbrough ECBE, Ross J Jr. Transseptal left heart catheterization—a review of 450 studies and description of an improved technique. Circulation (1962) 25:15–21.
[17] De Ponti R, Zardini M, Storti C, Longobardi M, Salerno-Uriarte JA. Trans-septal catheterization for radiofrequency catheter ablation of cardiac arrhythmias. Results and safety of a simplified method. Eur Heart J (1998) 19:943–50.
[18] Daoud EG, Kalbfleisch SJ, Hummel JD. Intracardiac echocardiography to guide transseptal left heart catheterization for radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1999) 10:358–63.[Web of Science][Medline]
[19] Sra J, Narayan G, Krum D, Malloy A, Cooley R, Bhatia A, et al. Computed tomography-fluoroscopy image integration-guided catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2007) 18:409–14.[CrossRef][Web of Science][Medline]
[20] Ren J-F, Marchlinski FE, Callans DJ, Zado ES. Intracardiac Doppler echocardiographic quantification of pulmonary vein flow velocity: an effective technique for monitoring pulmonary vein ostia narrowing during focal atrial fibrillation ablation. J Cardiovasc Electrophysiol (2002) 13:1076–81.[CrossRef][Web of Science][Medline]
[21] Epstein LM, Mitchell MA, Smith TW, Haines DE. Comparative study of fluoroscopy and intracardiac echocardiographic guidance for the creation of linear atrial lesions. Circulation (1998) 98:1796–801.
[22] Wazni OM, Rossillo A, Marrouche NF, Saad EB, Martin DO, Bhargava M, et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol (2005) 16:576–81.[CrossRef][Web of Science][Medline]
[23] Cooper JM, Epstein LM. Use of intracardiac echocardiography to guide ablation of atrial fibrillation. Circulation (2001) 104:3010–3.
[24] Ren J-F, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol (2004) 43:1861–7.
[25] Sra J, Krum D, Hare J, Okerlund D, Thompson H, Vass M, et al. Feasibility and validation of registration of three-dimensional left atrial models derived from computed tomography with a noncontact cardiac mapping system. Heart Rhythm (2005) 2:55–63.[CrossRef][Web of Science][Medline]
[26] Kistler PM, Earley MJ, Harris S, Abrams D, Ellis S, Sporton SC, et al. Validation of three-dimensional cardiac image integration: use of integrated CT image into electroanatomic mapping system to perform catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 17:341–8.[CrossRef][Web of Science][Medline]
[27] Dong JUN, Dickfeld T, Dalal D, Cheema A, Vasamreddy CR, Henrikson CA, et al. Initial experience in the use of integrated electroanatomic mapping with three-dimensional MR/CT images to guide catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 17:459–66.[CrossRef][Web of Science][Medline]
[28] Ector J, De Buck S, Adams J, Dymarkowski S, Bogaert J, Maes F, et al. Cardiac three-dimensional magnetic resonance imaging and fluoroscopy merging: a new approach for electroanatomic mapping to assist catheter ablation. (2005) 3769–76.
[29] Martinek M, Nesser H-J, Aichinger J, Boehm G, Purerfellner H. Impact of Integration of Multislice Computed Tomography Imaging into Three-Dimensional Electroanatomic Mapping on Clinical Outcomes, Safety, and Efficacy Using Radiofrequency Ablation for Atrial Fibrillation. J Cardiovasc Electrophysiol (2007) 30:1215–23.
[30] Orlov MV, Hoffmeister P, Chaudhry GM, Almasry I, Gijsbers GHM, Swack T, et al. Three-dimensional rotational angiography of the left atrium and esophagus—a virtual computed tomography scan in the electrophysiology lab? Heart Rhythm (2007) 4:37–43.[CrossRef][Web of Science][Medline]
[31] Thiagalingam A, Manzke R, DAvila A, Ho I, Locke AH, Ruskin JN, et al. Intraprocedural volume imaging of the left atrium and pulmonary veins with rotational x-ray angiography: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 19:293–300.[CrossRef][Web of Science][Medline]
[32] Marrouche NF, Guenther J, Segerson NM, Daccarett M, Rittger H, Marschang H, et al. Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J Cardiovasc Electrophysiol (2007) 18:583–8.[CrossRef][Web of Science][Medline]
[33] Good E, Oral H, Lemola K, Han J, Tamirisa K, Igic P, et al. Movement of the esophagus during left atrial catheter ablation for atrial fibrillation. J Am Coll Cardiol (2005) 46:2107–10.
[34] Ren J-F, Lin D, Marchlinski FE, Callans DJ, Patel V. Esophageal imaging and strategies for avoiding injury during left atrial ablation for atrial fibrillation. Heart Rhythm (2006) 3:1156–61.[Web of Science][Medline]
[35] Piorkowski C, Hindricks G, Schreiber D, Tanner H, Weise W, Koch A, et al. Electroanatomic reconstruction of the left atrium, pulmonary veins, and esophagus compared with the true anatomy on multislice computed tomography in patients undergoing catheter ablation of atrial fibrillation. Heart rhythm (2006) 3:317–27.[CrossRef][Web of Science][Medline]
[36] Cummings JE, Schweikert RA, Saliba WI, Burkhardt JD, Brachmann J, Gunther J, et al. Assessment of temperature, proximity, and course of the esophagus during radiofrequency ablation within the left atrium. Circulation (2005) 112:459–64.
[37] Reddy VY, Neuzil P, Malchano ZJ, Vijaykumar R, Cury R, Abbara S, et al. View-synchronized robotic image-guided therapy for atrial fibrillation ablation: experimental validation and clinical feasibility. Circulation (2007) 115:2705–14.
[38] Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology (2007) 243:690–5.
[39] Welch PJ, Afridi I, Joglar JA, Sheehan CJ, Zagrodzky JD, Abraham TP, et al. Effect of radiofrequency ablation on atrial mechanical function in patients with atrial flutter. Am J Cardiol (1999) 84:420–5.[CrossRef][Web of Science][Medline]
[40] Reant P, Lafitte S, Jais P, Serri K, Weerasooriya R, Hocini M, et al. Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation. Circulation (2005) 112:2896–903. (Epub 31 October 2005).
[41] Takahashi Y, ONeill MD, Hocini M, Reant P, Jonsson A, Jais P, et al. Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. J Am Coll Cardiol (2007) 49:1306–14.
[42] Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 351:2373–83.
[43] Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 111:1100–5. (Epub 21 February 2005).
[44] Saad EB, Rossillo A, Saad CP, Martin DO, Bhargava M, Erciyes D, et al. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation (2003) 108:3102–7. Epub 17 November 2003.
[45] Packer DL, Keelan P, Munger TM, Breen JF, Asirvatham S, Peterson LA, et al. Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation. Circulation (2005) 111:546–54.
[46] Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation (2004) 109:2724–6. (Epub 24 May 2004).
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


